MYOC and glaucoma: Prior to undertaking experiments, cell types were validated by quantifying Myocilin (MYOC) mRNA/protein in control HTM-5 cells treated with Dexamethasone (DEX) and the expression levels of glaucoma-related genes in glaucomatous HTM-3 cells.